← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2013Last known activity
Jul 1, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT02502032Sponsor investigatorPhase 3Jul 1, 2015
- NCT02502032Study directorPhase 3Jul 1, 2015
- NCT01918241CollaboratorPhase 2Jul 1, 2013
- NCT02481193Lead sponsorPhase 3Mar 1, 2013
- NCT02481193Reponsible party - principal investigatorPhase 3Mar 1, 2013
Details
- Last known activity
- Jul 1, 2015